G&E Herbal Biotechnology Statistics

Total Valuation

TPEX:4911 has a market cap or net worth of TWD 3.26 billion. The enterprise value is 2.80 billion.

Market Cap	3.26B
Enterprise Value	2.80B

Important Dates

The last earnings date was Thursday, May 8, 2025.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

TPEX:4911 has 59.00 million shares outstanding. The number of shares has decreased by -0.23% in one year.

Current Share Class	59.00M
Shares Outstanding	59.00M
Shares Change (YoY)	-0.23%
Shares Change (QoQ)	-0.32%
Owned by Insiders (%)	25.14%
Owned by Institutions (%)	n/a
Float	44.17M

Valuation Ratios

The trailing PE ratio is 27.36.

PE Ratio	27.36
Forward PE	n/a
PS Ratio	11.92
PB Ratio	3.75
P/TBV Ratio	4.43
P/FCF Ratio	19.05
P/OCF Ratio	18.42
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 19.20, with an EV/FCF ratio of 16.38.

EV / Earnings	23.58
EV / Sales	10.24
EV / EBITDA	19.20
EV / EBIT	20.66
EV / FCF	16.38

Financial Position

The company has a current ratio of 3.64, with a Debt / Equity ratio of 0.00.

Current Ratio	3.64
Quick Ratio	3.44
Debt / Equity	0.00
Debt / EBITDA	0.01
Debt / FCF	0.01
Interest Coverage	3,394.45

Financial Efficiency

Return on equity (ROE) is 14.39% and return on invested capital (ROIC) is 10.25%.

Return on Equity (ROE)	14.39%
Return on Assets (ROA)	8.99%
Return on Invested Capital (ROIC)	10.25%
Return on Capital Employed (ROCE)	15.59%
Revenue Per Employee	7.02M
Profits Per Employee	3.05M
Employee Count	39
Asset Turnover	0.29
Inventory Turnover	1.97

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +1.78% in the last 52 weeks. The beta is -0.90, so TPEX:4911's price volatility has been lower than the market average.

Beta (5Y)	-0.90
52-Week Price Change	+1.78%
50-Day Moving Average	54.19
200-Day Moving Average	55.62
Relative Strength Index (RSI)	58.53
Average Volume (20 Days)	20,417

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:4911 had revenue of TWD 273.77 million and earned 118.95 million in profits. Earnings per share was 2.02.

Revenue	273.77M
Gross Profit	228.11M
Operating Income	135.78M
Pretax Income	141.61M
Net Income	118.95M
EBITDA	145.42M
EBIT	135.78M
Earnings Per Share (EPS)	2.02

Full Income Statement

Balance Sheet

The company has 459.69 million in cash and 1.53 million in debt, giving a net cash position of 458.16 million or 7.77 per share.

Cash & Cash Equivalents	459.69M
Total Debt	1.53M
Net Cash	458.16M
Net Cash Per Share	7.77
Equity (Book Value)	870.07M
Book Value Per Share	14.77
Working Capital	364.17M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 177.17 million and capital expenditures -5.92 million, giving a free cash flow of 171.25 million.

Operating Cash Flow	177.17M
Capital Expenditures	-5.92M
Free Cash Flow	171.25M
FCF Per Share	2.90

Full Cash Flow Statement

Margins

Gross margin is 83.32%, with operating and profit margins of 49.60% and 43.45%.

Gross Margin	83.32%
Operating Margin	49.60%
Pretax Margin	51.72%
Profit Margin	43.45%
EBITDA Margin	53.12%
EBIT Margin	49.60%
FCF Margin	62.55%

Dividends & Yields

This stock pays an annual dividend of 0.76, which amounts to a dividend yield of 1.37%.

Dividend Per Share	0.76
Dividend Yield	1.37%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	2
Payout Ratio	26.70%
Buyback Yield	0.23%
Shareholder Yield	1.60%
Earnings Yield	3.65%
FCF Yield	5.25%

Dividend Details

Stock Splits

The last stock split was on August 20, 2024. It was a forward split with a ratio of 1.06.

Last Split Date	Aug 20, 2024
Split Type	Forward
Split Ratio	1.06

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a